232 related articles for article (PubMed ID: 18567921)
1. Neurological symptoms and natural course of xeroderma pigmentosum.
Anttinen A; Koulu L; Nikoskelainen E; Portin R; Kurki T; Erkinjuntti M; Jaspers NG; Raams A; Green MH; Lehmann AR; Wing JF; Arlett CF; Marttila RJ
Brain; 2008 Aug; 131(Pt 8):1979-89. PubMed ID: 18567921
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
[TBL] [Abstract][Full Text] [Related]
3. Expansion of the genotypic and phenotypic spectrum of xeroderma pigmentosum in Chinese population.
Zhang J; Cheng R; Yu X; Sun Z; Li M; Yao Z
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):58-63. PubMed ID: 27982466
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group A carrying the founder mutation in Japan.
Ueda T; Kanda F; Nishiyama M; Nishigori C; Toda T
J Neurol Sci; 2017 Oct; 381():103-106. PubMed ID: 28991657
[TBL] [Abstract][Full Text] [Related]
7. Differences in peripheral neuropathy in xeroderma pigmentosum complementation groups A and D as evaluated by nerve conduction studies.
Lehky TJ; Sackstein P; Tamura D; Quezado M; Wu T; Khan SG; Patronas NJ; Wiggs E; Brewer CC; DiGiovanna JJ; Kraemer KH
BMC Neurol; 2021 Oct; 21(1):393. PubMed ID: 34627174
[TBL] [Abstract][Full Text] [Related]
8. Xeroderma pigmentosum complementation group G patient with a novel homozygous missense mutation and no neurological abnormalities.
Moriwaki S; Takigawa M; Igarashi N; Nagai Y; Amano H; Ishikawa O; Khan SG; Kraemer KH
Exp Dermatol; 2012 Apr; 21(4):304-7. PubMed ID: 22417308
[TBL] [Abstract][Full Text] [Related]
9. [Siblings with xeroderma pigmentosum group A showing mild cutaneous and various neurological manifestations].
Kuru S; Yasuma M; Sakai M; Konagaya M; Moriwaki S
Rinsho Shinkeigaku; 2006 Feb; 46(2):134-9. PubMed ID: 16619838
[TBL] [Abstract][Full Text] [Related]
10. Auditory analysis of xeroderma pigmentosum 1971-2012: hearing function, sun sensitivity and DNA repair predict neurological degeneration.
Totonchy MB; Tamura D; Pantell MS; Zalewski C; Bradford PT; Merchant SN; Nadol J; Khan SG; Schiffmann R; Pierson TM; Wiggs E; Griffith AJ; DiGiovanna JJ; Kraemer KH; Brewer CC
Brain; 2013 Jan; 136(Pt 1):194-208. PubMed ID: 23365097
[TBL] [Abstract][Full Text] [Related]
11. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
[TBL] [Abstract][Full Text] [Related]
12. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
13. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
[TBL] [Abstract][Full Text] [Related]
15. Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions.
Sethi M; Lehmann AR; Fawcett H; Stefanini M; Jaspers N; Mullard K; Turner S; Robson A; McGibbon D; Sarkany R; Fassihi H
Br J Dermatol; 2013 Dec; 169(6):1279-87. PubMed ID: 23889214
[TBL] [Abstract][Full Text] [Related]
16. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
[TBL] [Abstract][Full Text] [Related]
17. The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D).
Lai JP; Liu YC; Alimchandani M; Liu Q; Aung PP; Matsuda K; Lee CC; Tsokos M; Hewitt S; Rushing EJ; Tamura D; Levens DL; Digiovanna JJ; Fine HA; Patronas N; Khan SG; Kleiner DE; Oberholtzer JC; Quezado MM; Kraemer KH
Acta Neuropathol Commun; 2013 May; 1():4. PubMed ID: 24252196
[TBL] [Abstract][Full Text] [Related]
18. Analysis of point mutations in an ultraviolet-irradiated shuttle vector plasmid propagated in cells from Japanese xeroderma pigmentosum patients in complementation groups A and F.
Yagi T; Tatsumi-Miyajima J; Sato M; Kraemer KH; Takebe H
Cancer Res; 1991 Jun; 51(12):3177-82. PubMed ID: 2039995
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity to UV radiation of fibroblasts from a Japanese group A xeroderma pigmentosum patient with mild neurological abnormalities.
Sato K; Watatani M; Ikenaga M; Kozuka T; Kitano Y; Yoshikawa K; Mimaki T; Abe J; Sugita T
Br J Dermatol; 1987 Jan; 116(1):101-8. PubMed ID: 3814505
[TBL] [Abstract][Full Text] [Related]
20. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
